On 6/28/24, ImmuCell Corp (NASDAQ: ICCC) stock enjoyed a major increase of 11.2%, closing at $4.85. Trading volume in this advance was normal. Relative to the market the stock has been weak over the last nine months but has risen 11.5% during the last week.
Current PriceTarget Research Rating
ICCC is expected to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
ImmuCell has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. ImmuCell has a poor Power Rating of 25 and a very low Appreciation Score of 14, leading to the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment